FDA
-
-
-
-
-
-
-
Innovus Pharma Reports Quarterly Revenue for the First Quarter 2019 of $5.4 Million, a 18.0% Increase from Comparable Quarter in the Prior Year
-
-
-
-
-
-
-
Innovus Pharma (INNV) Granted Medicare Reimbursement Approval for GlucoGorx Blood Glucose Monitoring System & GlucoGorx Blood Glucose Test Strip Products
-
-
-
-
-
-
-
Innovus Pharma Announces Its Direct Launch of Apeaz™, a Cream for Arthritis Pain Relief, in Canada
-
-
-
-
-
-
-
Innovus Pharmaceuticals Reports Nine Month Net Revenue of $6.4 million and Net Loss Decrease of 51.6% Compared to the Same Period in 2016
-
-
-
-
-
-
-
Innovus Pharma’s Partner Luminarie Receives Approval for Zestra® for Female Sexual Arousal Disorder as a Medical Device I from Australia’s Therapeutic Goods Administration
-
-
-
-
-
-
-
Innovus Pharma Expands its Executive Management Team with the Addition of Randy Berholtz as its Executive Vice President, Corporate Development and General Counsel
322,093 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

